The non‐proteolytically active thrombin peptide TP508 stimulates angiogenic sprouting

Thrombin is a serine protease that promotes platelet aggregation, blood coagulation, and tissue repair. A peptide derived from a non‐proteolytically active region of thrombin, TP508, also promotes tissue repair and increased vascularity, yet does not activate platelet and inflammatory cascades. TP508 binds to cells with high affinity and stimulates cells independent of the proteolytically active thrombin receptors (PARs) and thus is considered to activate a non‐proteolytically active receptor (non‐PAR) pathway. Using a model of angiogenic sprouting, we further defined the angiogenic potential of TP508 and investigated the role of non‐proteolytic, thrombin‐mediated pathways in angiogenesis. The assay involves measuring angiogenic sprouting from cultured, intact microvessel fragments. In this assay, TP508 stimulated angiogenic sprouting to an extent similar to or greater than the potent angiogenic factor, VEGF. However, TP508 had no significant effect on the number of sprouts that formed per vessel. In contrast to TP508, proteolytically active receptor agonists had no effect or inhibited angiogenic sprouting. The increased sprouting activity stimulated by TP508 was VEGF dependent but did not involve an increase in VEGF mRNA expression above baseline levels. These results suggest that TP508 acts early in angiogenesis and directly on microvascular cells to accelerate sprouting, but not to induce more sprouting, in a manner different than the intact thrombin molecule. © 2005 Wiley‐Liss, Inc.

[1]  M. Ward,et al.  Parathyroid-induced angiogenesis is VEGF-dependent. , 2000, Surgery.

[2]  Fang Wang,et al.  Mouse fibroblasts defective in thrombin mitogenesis possess functional proteolytically activated receptor for thrombin: Requirement for a second signaling pathway , 1994, Journal of cellular physiology.

[3]  C. Flordellis,et al.  On the mode of action of thrombin-induced angiogenesis: thrombin peptide, TP508, mediates effects in endothelial cells via αvβ3 integrin , 2004, Thrombosis and Haemostasis.

[4]  M. Robson,et al.  Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. , 1992, The Journal of clinical investigation.

[5]  L. Sower,et al.  Thrombin peptide, TP508, induces differential gene expression in fibroblasts through a nonproteolytic activation pathway. , 1999, Experimental cell research.

[6]  Robert V Farese,et al.  A dual thrombin receptor system for platelet activation , 1998, Nature.

[7]  H. Kanaide,et al.  Role of protease-activated receptors in the vascular system. , 2003, Journal of atherosclerosis and thrombosis.

[8]  N. Prévost,et al.  Thrombin Responses in Human Endothelial Cells , 2000, The Journal of Biological Chemistry.

[9]  R. Busse,et al.  Thrombin Causes Vascular Endothelial Growth Factor Expression in Vascular Smooth Muscle Cells: Role of Reactive Oxygen Species , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[10]  C. Flordellis,et al.  On the mode of action of thrombin-induced angiogenesis: thrombin peptide, TP508, mediates effects in endothelial cells via alphavbeta3 integrin. , 2004, Thrombosis and haemostasis.

[11]  D. Cromack,et al.  Acceleration of soft tissue repair by a thrombin-derived oligopeptide. , 1992, The Journal of surgical research.

[12]  G. D. Hunter,et al.  Proteinase-activated receptors. , 2001, Pharmacological reviews.

[13]  N. Tsopanoglou,et al.  On the Mechanism of Thrombin-induced Angiogenesis , 1999, The Journal of Biological Chemistry.

[14]  A. Habib,et al.  Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells: possible relevance to HIF‐1α , 2003, Journal of thrombosis and haemostasis : JTH.

[15]  S. Brodsky.  Coagulation, Fibrinolysis and Angiogenesis: New Insights from Knockout Mice , 2002, Nephron Experimental Nephrology.

[16]  J. Matsoukas,et al.  Modulation of angiogenesis and progelatinase a by thrombin receptor mimetics and antagonists. , 2001, Endothelium : journal of endothelial cell research.

[17]  S. Coughlin,et al.  PAR3 is a cofactor for PAR4 activation by thrombin , 2000, Nature.

[18]  James B. Hoying,et al.  Angiogenic potential of microvessel fragments established in three-dimensional collagen gels , 1996, In Vitro Cellular & Developmental Biology - Animal.

[19]  P. Carmeliet.  Angiogenesis in health and disease , 2003, Nature Medicine.

[20]  D. Carney,et al.  Acceleration of full‐thickness wound healing in normal rats by the synthetic thrombin peptide, TP508 , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[21]  Gabriel Gruionu,et al.  Rapid Perfusion and Network Remodeling in a Microvascular Construct After Implantation , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[22]  W. Aird,et al.  Thrombin and Phenotypic Modulation of the Endothelium , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[23]  J. Herbert,et al.  Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway. , 1994, The Biochemical journal.

[24]  K. Mann,et al.  Identification of a thrombin sequence with growth factor activity on macrophages. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Sower,et al.  Thrombin peptide TP508 accelerates closure of dermal excisions in animal tissue with surgically induced ischemia , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[26]  J. S. Bergmann,et al.  Thrombin peptide, TP508, stimulates angiogenic responses in animal models of dermal wound healing, in chick chorioallantoic membranes, and in cultured human aortic and microvascular endothelial cells. , 2000, General pharmacology.

[27]  J. Herbert,et al.  Nonproteolytic activation of the thrombin receptor promotes human umbilical vein endothelial cell growth but not intracellular CA2+, prostacyclin, or permeability. , 1997, Biochemical pharmacology.

[28]  K. Glenn,et al.  Synthetic peptides bind to high-affinity thrombin receptors and modulate thrombin mitogenesis. , 1988, Peptide research.

[29]  W. Aird,et al.  Vascular Bed–specific Expression of an Endothelial Cell Gene Is Programmed by the Tissue Microenvironment , 1997, The Journal of cell biology.

[30]  R. Scarborough,et al.  Ligand Cross-reactivity within the Protease-activated Receptor Family* , 1996, The Journal of Biological Chemistry.

[31]  S. Coughlin,et al.  PAR 3 is a cofactor for PAR 4 activation by thrombin , 2022 .

[32]  S. Karpatkin,et al.  Thrombin Induces Increased Expression and Secretion of VEGF from Human FS4 Fibroblasts, DU145 Prostate Cells and CHRF Megakaryocytes , 2001, Thrombosis and Haemostasis.

[33]  N. Goldsack,et al.  Molecules in focus Thrombin , 1998 .

[34]  J. Pouysségur,et al.  Angiogenesis and G-protein-coupled receptors: signals that bridge the gap , 2001, Oncogene.

[35]  N. Tsopanoglou,et al.  Mechanism of thrombin-induced angiogenesis. , 2001, Biochemical Society transactions.